{
    "code": "02012039",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02012039",
    "time": "2015-08-23 08:25:14",
    "許可證字號": "衛署藥輸字第012039號",
    "註銷狀態": "已註銷",
    "註銷日期": "88\/09\/22",
    "註銷理由": "未展延而逾期者",
    "有效日期": "76\/10\/07",
    "發證日期": "72\/12\/17",
    "許可證種類": "製　劑",
    "舊證字號": "13006924",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00201203900",
    "中文品名": "新哈健",
    "英文品名": "NEOPHAGEN INJECTION",
    "適應症": "過敏性支氣管炎、支氣管氣喘、藥物過敏、腎炎、過敏性鼻炎",
    "劑型": "270注射劑",
    "包裝": "安瓿",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "主成分略述": "L-CYSTEINE, GLYCINE (EQ TO AMINOACETIC ACID)(EQ TO GLYCOCOLL), GLYCYRRHIZINIC ACID (EQ TO GLYCYRRHETINIC ACID GLYCOSIDE)(EQ TO GLYCYRRHIZIC ACID )",
    "限制項目": [
        "02輸入"
    ],
    "申請商名稱": "0505801100  正怡興貿易股份有限公司",
    "申請商地址": "台北巿錦州街４巷１號",
    "主製造廠": {
        "製造廠名稱": "F260319000  TAISHO PHARMACEUTICAL CO. LTD.",
        "製造廠廠址": "403, YOSHINOCHO, 1-CHOME, OHMIYASHI, SAITAMAKEN, JAPAN24-1, TAKATA 3-CHOME, TOSHIMAKU, TOKYO, JAPAN",
        "製造廠公司地址": "24-1, TAKATA 3-CHOME, TOSHIMAKU, TOKYO, JAPAN",
        "製造廠國別": "JAPAN",
        "製程": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "4020100502",
            "成分名稱": "L-CYSTEINE",
            "含量描述": "5",
            "含量": "5.0000000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "4020102400",
            "成分名稱": "GLYCINE (EQ TO AMINOACETIC ACID)(EQ TO GLYCOCOLL)",
            "含量描述": "100",
            "含量": "100.0000000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "9200004600",
            "成分名稱": "GLYCYRRHIZINIC ACID (EQ TO GLYCYRRHETINIC ACID GLYCOSIDE)(EQ TO GLYCYRRHIZIC ACID )",
            "含量描述": "10",
            "含量": "10.0000000000",
            "單位": "MG"
        }
    ]
}